Kalvista Pharmaceuticals Inc (KALV) FY2026Q1 Earning Prediction

09/11 04:00:00

Pre-Market

Kalvista Pharmaceuticals Inc (KALV) is set to release its earnings performance on 09/11 04:00:00 in Pre-Market trading. Consensus forecasts predict a revenue of 2.09M and an earnings per share (EPS) of -0.91 for the . With Intellectia's exclusive AI algorithms, users can predict whether the earnings will beat or miss expectations before the report drops. Leverage this powerful tool to strategize and position your trades ahead of the earnings release!

Estimate

Actual

Surprise

RevenueMISS

2.09M

1.43M

-31.73%

EPS-

-0.91

AI Summary

Attend Webcast

Earnings Surprise Analysis

The chart displays the extent of earnings surprises and corresponding stock price movements for each earnings event.

Revenue

EPS

KALV Transcript

KalVista Pharmaceuticals, Inc. (KALV) Presents at Jefferies London Healthcare Conference 2025 Transcript

Neutral11-24

KalVista Pharmaceuticals, Inc. (KALV) Q3 2025 Earnings Call Transcript

Unknown11-11

The earnings call summary presents a mixed picture. While EKTERLY's early market adoption and strong focus on high-burden patients are positive, the lack of specific financial guidance and uncertainty around revenue projections and pricing in Germany introduce caution. The Q&A reveals concerns about demand fluctuations and management's reluctance to provide clear revenue guidance, which tempers overall optimism. The neutral sentiment reflects these balanced positive and negative factors, with no strong catalysts or deterrents to drive significant stock price movement in the short term.

KalVista Pharmaceuticals, Inc. (KALV) Q1 2026 Earnings Call Transcript

Positive9-11

The earnings call summary indicates positive sentiment with strong product development and business updates, including EKTERLY's successful launch and positive feedback on side effects. The Q&A section highlights minimal adverse events and growing patient adoption, which are positive indicators. Despite some unclear management responses, the overall sentiment leans positive due to optimistic guidance and market growth projections.

KalVista Pharmaceuticals, Inc. (KALV) Presents At Cantor Global Healthcare Conference 2025 Transcript

Neutral9-7

KALV Report

KalVista Pharmaceuticals, Inc. 10-Q

10-Q

2024-12-05

KalVista Pharmaceuticals, Inc. 10-Q

10-Q

2024-09-05

KalVista Pharmaceuticals, Inc. 10-K

10-K

2024-07-11

KalVista Pharmaceuticals, Inc. 10-Q

10-Q

2024-03-11

Frequently Asked Questions

What is the Kalvista Pharmaceuticals Inc FY2026Q1 Earnings Release Date and Time?

Kalvista Pharmaceuticals Inc (KALV) is scheduled to release its FY2026Q1 earnings report onSep 11, 2025, Pre-Market(approximately 4:00 PM ET). This timing allows investors to react during after-hours trading, with a conference call typically following shortly after.

What Are the Consensus Forecasts for Kalvista Pharmaceuticals Inc FY2026Q1 Revenue and EPS?

Analysts' consensus predicts 2.09M in revenue and an EPS of -0.91 for Kalvista Pharmaceuticals Inc's FY2026Q1.

What Does Intellectia's AI Predict for Kalvista Pharmaceuticals Inc FY2026Q1 Earnings?

Intellectia's exclusive AI algorithms forecast a forKalvista Pharmaceuticals Inc's FY2026Q1 earnings, with a prediction date of Sep 11, 2025. Kalvista Pharmaceuticals Inc

How Can I Use This Earnings Prediction to Trade KALV Stock?

Leverage Intellectia's AI forecast to position trades ahead of theSep 11, 2025 release—consider calls for a beat scenario or protective puts for misses. Focus on pre-market volatility, and use the scenario probabilities to build strategies around revenue and guidance updates.

How Accurate Is Intellectia's AI for Earnings Predictions Like Kalvista Pharmaceuticals Inc FY2026Q1?

Intellectia's predictions are backed by rigorous backtesting, showing a high hit rate for Beat and Miss calls compared to traditional analysis. While no forecast is 100% certain, we provide probability-based scenarios (e.g., 50% chance of a *Beat*) and detailed rationales to help you make informed decisions. Combine our insights with your strategy for the best results—it's like having a co-pilot for earnings season! Empowering users to strategize trades before reports drop.

How does AI Earnings Prediction generate its forecasts?

AI Earnings Prediction uses advanced Large Language Models (LLMs) to analyze a wealth of data, including past earnings transcripts, real-time market sentiment, analyst insights, and company news from the last three months. It focuses on key indicators like revenue, EPS, and margins to predict whether a company will *Beat*, *Miss*, or remain Neutral relative to market expectations. Think of it as a super-smart analyst crunching numbers and news 24/7 to give you a trading edge!

When are the predictions available, and how often are they updated?

Predictions are generated two days before a company’s earnings release (e.g., 5:00 PM ET on Feb 13 for a Feb 15 report) to capture the latest market and company data. They’re updated in real-time if significant news breaks, ensuring you get fresh insights.

Can I use AI Earnings Prediction for all types of stocks?

Currently, AI Earnings Prediction focuses on companies with market caps above $40 billion, covering major players like SPG, AAPL, MSFT, and NVDA for the 2024-2025 earnings seasons. We prioritize high-impact stocks with robust data to ensure reliable forecasts. Stay tuned as we expand coverage to more companies based on user demand!